福井大学医学部

消化器内科学

研究業績

学術論文

2024

原著論文(審査有)

  1. Midori Y, Nosaka T, Hiramatsu K, Akazawa Y, Tanaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients, Frontiers in Cellular and Infection Microbiology, 20240408, DOI: 10.3389/fcimb.2024.1371429, #4.6
  2. Nosaka T, Murata Y, Akazawa Y, Tanaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Imamura Y, Nakamoto Y: Programmed Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor and Monitor of Response to Atezolizumab plus Bevacizumab Treatment in Patients with Hepatocellular Carcinoma, Cancers, 16(9), 1785-1785, 20240506, DOI: 10.3390/cancers16091785, #4.5
  3. Matsuda H, Nosaka T, Hiramatsu K, Takahashi K, Naito T, Ofuji K, Ohtani M, Imamura Y, Iwasaki H, Nakamoto Y: Analysis of peripheral immune markers to predict liver injury during COVID‑19, Clinical Journal of Gastroenterology, 17(4), 797-798, 20240605, DOI: 10.1007/s12328-024-01995-y, #1.0
  4. Murata Y, Nosaka T, Akazawa Y, Tanaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab, Cancers (Basel), 16(13), 2410-2410, 20240629, DOI: 10.3390/cancers16132410, #4.5
  5. Nosaka T, Murata Y, Akazawa Y, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Changes of circulating tumor cells expressing CD90 and EpCAM in early-phase of atezolizumab and bevacizumab for hepatocellular carcinoma, Heliyon, 10(14), 20240730, DOI: 10.1016/j.heliyon.2024.e34441, #3.4
  6. Akazawa Y, Ohtani M, Nosaka T, Takahashi K, Naito T, Matsuda H, Nakamoto Y: Usefulness of pancreatic volume quantitative analysis as a predictor of development and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis, Pancreatology., 24(5), 698-705, 20240824, DOI: 10.1016/j.pan.2024.06.002, #2.8
  7. Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Ido A, Miki D, Kurosaki M, Yoshiji H, Sakamori R, Kuroda H, Yatsuhashi H, Yamashita T, Hiasa Y, Kato N, Miyaaki H, Ueno Y, Itoh Y, Matsuura K, Takami T, Asahina Y, Suda G, Akuta N, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Miyazaki M, Nozaki Y, Sobue S, Yano H, Miyaki T, Moriuchi A, Hori T, Shirai K, Murai K, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T: Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy, Hepatology research, 20241029, DOI: 10.1111/hepr.14131, #3.9
  8. Tanaka T, Nosaka T, Akazawa Y, Takahashi K, Naito T, Ohtani M, Hiramatsu K, Nakamoto Y: Arteriovenous malformations of the colon evaluated using hemodynamic parameters in color Doppler EUS, VIDEOGIE, 9(10), 457-459, 202410, DOI: 10.1016/j.vgie.2024.06.007
  9. Miyake Y, Tanaka K, Nagata C, Furukawa S, Andoh A, Yokoyama T, Yoshimura N, Nakamoto Y, Hiramatsu K, et al: Case-control study of IL23R rs76418789 polymorphism, smoking, and ulcerative colitis in Japan, CYTOKINE, 183, 202411, DOI: 10.1016/j.cyto.2024.156743, #3.7
  10. Takahashi K, Nosaka T, Murata Y, Sugata R, Akazawa Y, Tanaka T, Naito T, Matsuda H, Ohtani M, Suto H, Nakamoto Y: Influence of antiplatelet drugs on gastric ulcer healing after endoscopic submucosal dissection in patients with early gastric cancer, Digestive endoscopy open, 5(1), e70070-e70070, 20250211, DOI: 10.1002/ deo2.70070, #1.4
  11. Naito T, Nosaka T, Tanaka T, Akazawa Y, Takahashi K, Ohtani M, Nakamoto Y: Usefulness of an artificial intelligence-based colonoscopy report generation support system, Clinical endoscopy, 20250219, DOI: 10.5946/ce.2024.213, #2.1
  12. Nakashima K, Nagaya T, Iwaya M, Hiramatsu K, Uehara T, Nakamoto Y, Ishizuka T, Kobayashi M: Vascular E-selectin Expression Recognized by the U12-12 Monoclonal Antibody as a Predictive Marker for Steroid Resistance in Immune Checkpoint Inhibitor-related Colitis, Journal of histochemistry & cytochemistry, 73(1-2), 81-88, 20250224, DOI: 10.1369/00221554251320703, #1.9
  13. Nosaka T, Naito T, Akazawa Y, Takahashi K, Matsuda H, Ohtani M, Nishizawa T, Okamoto H, Nakamoto Y: Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems, Public Library of Science one, 20(3), e0314581-e0314581, 20250306, DOI: 10.1371/journal.pone.0314581, #2.9

2023

原著論文(審査有)

  1. Matsuda H, Nosaka T, Hiramatsu K, Takahashi K, Naito T, Ofuji K, Ohtani M, Imamura Y, Iwasaki H, Nakamoto Y:Histology and cytokine levels in hepatic injury accompanying a case of non-severe COVID-19, Clinical Journal of Gastroenterology, 16(2), 270-278, 202304, DOI: 10.1007/s12328-023-01755-4(症例報告), #0.24
  2. Namikawa S, Nosaka T, Matsuda H, Akazawa Y, Takahashi K, Naito T, Ohtani M, Nakamoto Y: High correlation of hepatic shear wave velocity with esophageal varices complication rate in patients with chronic liver diseases, BMC Gastroenterology, 23(1), 20230522, DOI:10.1186/s12876-023-02821-4, #2.848
  3. Kainuma M, Kawakatsu S, Kim J, Ouma S, Iritani O, Yamashita K, Ohara T, Hirano S, Suda S , Hamano T, Hieda S, Yasui M, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K: Metabolic changes in the plasma of mild Alzheimer’s disease patients treated with Hachimijiogan, Frontiers in Pharmacology, 20230612, DOI: 10.3389/fphar.2023.1203349, #5.988
  4. Nosaka T, Murata Y, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Imamura Y, Goi T,Nakamoto Y: Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumorassociated macrophages, Biomedicine & Pharmacotherapy, 162, 202306, DOI: 10.1016/j.biopha.2023.114592,#7.419
  5. Tsubouti H, Onishi H, Ueda S, Shibata M, Enomoto S, Maeda F, Hirobe T, Chiba H, Ota Y, Daitoku S, Yamamoto T, Sasaki K, Hanzawa K, Kai Y, Hashimoto Y, Hamano T, Nakamoto Y: Contributing Factors and Ultrasonographic Findings of Fresh and Chronic Mixed Venous Thrombosis in Post-Earthquake: A Cross-Sectional Study, International Journal of Gerontology, 17, 189-194, 202307, DOI: org/10.6890/IJGE, #0.358
  6. Tsubokawa M, Fujitani J, Ashida K, Hayase M, Kobayashi N, Horita C, Sakashita M, Tokunaga T, Hamano T,Kikuta KI, Fujieda S: Potential of Rice-Flour Jelly Made from High-Amylose Rice as a Dysphagia Diet: Evaluation of Pharyngeal Residue by FEES, Dysphagia, 38(4), 1080-1086, 202308, DOI: 10.1007/s00455-022-10529-y, #2.733
  7. Shimamoto Y, Sasaki H, Kasuno K, Watanabe Y, Sakashita S, Nishikawa S, Nishimori K, Morita S, Nishikawa Y, Kobayashi M, Fukushima S, Enomoto S, Takahashi N, Hamano T, Sakamaki I, Ikawa H, Iwano M: Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report, BMC Nephrology, 24(1), 20230929, DOI: 10.1186/s12882-023-03319-7(症例報告), #2.585
  8. Nomiya H, Hamano T, Takaku N, Sasaki H, Usui K, Sanada S, Yamaguchi T, Kitazaki Y, Endo Y, Kamisawa T, Enomoto S, Shirafuji N, Matsunaga A, Ueno A, Ikawa M, Yamamura O, Hasegawa M, Kimura H, Nishino I, Nakamoto Y: Magnetic resonance imaging fi ndings of the lower limb muscles in anti-mitochondrial M2 antibodypositive myositis, Neuromuscular Disorders, 33(9), 74-80, 202309, DOI: 10.1016/j.nmd.2023.07.005, #3.538
  9. Kitazaki Y, Ikawa M, Hamano T, Sasaki H, Yamaguchi T, Enomoto S, Shirafuji N, Hayashi K, Yamamura O, Tsujikawa T, Okazawa H, Kimura H, Nakamoto Y: Magnetic Resonance Imaging Arterial Spin Labeling Hypoperfusion with Diff usion-weighted Image Hyperintensity is Useful for Diagnostic Imaging of Creutzfeldt-Jakob Disease, Frontiers in Neurology, 20231010, DOI: 10.3389/fneur.2023.1242615, #4.086
  10. Kitazaki Y, Yamamura O, Usui K, Ueno A, Sanada S, Sasaki H, Endo Y, Enomoto S, Ikawa M, Nakamoto Y, Hamano T: Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies, Intern Med, 62(3013), 3020, 20231015, DOI: 10.2169/ internalmedicine.0739-22(症例報告), #1.282
  11. Ohira M, Yoshii K, Aso Y, Hamano T, Takao M, et al: First evidence of tick-borne encephalitis (TBE) outside of Hokkaido Island in Japan, Emerging Microbes & Infections, 12(2), 20231114, DOI:10.1080/22221751.2023.2278898, #19.568
  12. Takimoto R, Kamigaki T, Ito H, Saito M, Takizawa K, Soejima K, Yasuda H, Ohogino K, Terai H, Tomita K, Miura M, Mizukoshi E, Miyashita T, Nakamoto Y, Hayashi K, Miwa S, Kitahara M, Takeuchi A, Kimura H, Mochizuki T, Sugie H, Seino K, Yamada Y, Takeuchi S, Makita K, Naitoh K, Yasumoto K, Yoshida Y, Inoue H, Kotake K, Ohshima K, Noda S, Okamoto M, Yoshimoto Y, Okada S,Okada S, Ibe H, Oguma E, Goto S,: Safety evaluation of immunecell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG), CYTOTHERAPY, 25(11), 1229-1235, 202311, DOI: 10.1016/j.jcyt.2023.06.007, #6.196
  13. Peyrin-Biroulet L, Allegretti J, Rubin D, Nakamoto Y, Zhan Q, et al: Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study, Gastroenterology, 165(6), 1443-1457,202312, DOI: 10.1053/j.gastro, #33.883
  14. Tahata Y, Hikita H, Mochida S, Enomoto N, Ido A, Kuroda H, Miki D, Kurosaki M, Hiasa Y, Sakamori R, Kawada N, Yamashita T, Suda G, Yatsuhashi H, Yoshiji H, Kato N, Takami T, Nakao K, Matsuura K, Asahina Y, Itoh Y, Tateishi R, Nakamoto Y, Takehara T, et al, : Posttreatment liver function, but not baseline liver function stratifi es patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus, J Gastroenterol, 58(12),1211-1221, 202312, DOI: 10.1007/s00535-023-02039-x, #6.3

2022

原著論文(審査有)

  1. Ueno A, Hamano T, Enomoto S, Shirafuji N, Nagata M, Kimura H, Ikawa M, Yamamura O, Yamanaka D, Ito T,Kimura Y, Kuriyama M, Nakamoto Y: Infl uences of Vitamin B12 Supplementation on Cognition and Homocysteinein Patients with Vitamin B12 Deficiency and Cognitive Impairment, Nutrients, 14(7), 1494, 20220402, DOI:10.3390/nu14071494, #6.706
  2. Okazawa H, Ikawa M, Tsujikawa T, Mori T, Makino A, Kiyono Y, Nakamoto Y, Kosaka H, Yoneda M: Cerebral Oxidative Stress in Early Alzheimer’s Disease Evaluated by 64 Cu-ATSM PET/MRI: A Preliminary Study,Antioxidants (Basel), 11(5), 1022, 20220522, DOI: 10.3390/antiox11051022, #7.675
  3. Takahashi K, Ofuji K, Nosaka T, Naito T, Matsuda H, Ohtani M, Hiramatsu K, Harada K, Naiki H, Nakamoto Y: Elderly onset congenital hepatic fi brosis with portal hypertension diagnosed after recurrent cholangitis: a case report, Clin J Gastroenterol, 15(3), 611-616, 202206, DOI: 10.1007/s12328-022-01620-w(症例報告)
  4. Ohira H, Takahashi A, Zeniya M, Abe M, Arinaga-Hino T, Joshita S, Takaki A, Nakamoto N, Kang JH, Suzuki Y,Sogo T, Inui A, Koike K, Harada K, Nakamoto Y, Kondo Y, Genda T, Tsuneyama K, Matsui T, Tanaka A: Clinical practice guidelines for autoimmune hepatitis, Hepatol Res, 52(7), 571-585, 202207, DOI: 10.1111/hepr.13776,#4.942
  5. Yamashita J, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Kobayashi M,Nakamoto Y: Cholesterol crystal embolism in multiple organs after transarterial chemoembolization for hepatocellular carcinoma: An autopsy case report, Medicine (Baltimore), 101(39), 20220930, DOI: 10.1097/MD.0000000000030769(症例報告), #1.817
  6. Yamaguchi T, Ikawa M, Enomoto S, Shirafuji N, Yamamura O, Tsujikawa T, Okazawa H, Kimura H, Nakamoto Y, Hamano T: Arterial spin labeling imaging for the detection of cerebral blood fl ow asymmetry in patients with corticobasal syndrome, Neuroradiology, 64(9), 1829-1837, 202209, DOI: 10.1007/s00234-022-02942-9, #2.995
  7. Naito T, Nosaka T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Imamura Y, Yamaguchi T, Nakamoto Y: Successful early diagnosis of monomorphic epitheliotropic intestinal T-cell lymphoma manifesting as chronic diarrhea and hypokalemia using video capsule endoscopy and double-balloon enteroscopy, Clin J Gastroenterol, 15(5), 913-919, 202210, DOI: 10.1007/s12328-022-01676-8(症例報告)
  8. Tsuji A, Hiramatsu K, Namikawa S, Yamamoto A, Midori Y, Murata Y, Tanaka T, Nosaka T, Naito T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Imamura Y, Lino S, Hasegawa M, Nakamoto Y: A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma, Clin J Gastroenterol, 15(5), 876-880, 202210, DOI:10.1007/s12328-022-01680-y(症例報告)
  9. Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S,Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K,Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y: An exploratory, openlabel,randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease, Front Pharmacol, 13, 991982,20221014, DOI: 10.3389/fphar.2022.991982, #5.988
  10. Tsubokawa M, Fujitani J, Ashida K, Hayase M, Kobayashi N, Horita C, Sakashita M, Tokunaga T, Hamano T,Kikuta KI, Fujieda S: Potential of Rice-Flour Jelly Made from High-Amylose Rice as a Dysphagia Diet: Evaluation of Pharyngeal Residue by FEES, Dysphagia, 202210, DOI:10.1007/s00455-022-10529-y, #2.733
  11. Hiramuki Y, Kure Y, Saito Y, Ogawa M, Ishikawa K, Mori-Yoshimura M, Oya Y, Takahashi Y, Dae-Seong Kim,Arai N, Mori C, Matsumura T, Hamano T, Nakamura K, Ikezoe K, Hayashi S, Goto Y, Noguchi S, Nishino I: Simultaneous measurement of the size and methylation of chromosome 4qA‑D4Z4 repeats in facioscapulohumeral muscular dystrophy by long‑read sequencing, Journal of Translational Medicine, 8(20), 202211, DOI: 10.1186/s12967-022-03743-7, #8.44
  12. Ueno A, Ikawa M, Maeda K, Tai K, Ito T, Shirafuji N, Yamamura O, Nakamoto Y, Hamano T: Persistent Severe Cerebral Edema with Neutrophil Infiltration Following Listeria Meningitis, Intern Med, 61(22),3431-3434, 20221115, DOI: 10.2169/internalmedicine.8291-21(症例報告), #1.282
  13. Ikeuchi T, Kanda M, Kitamura H, Morikawa F, Toru S, Nishimura C,Kasuga K, Tokutake T, Takahashi T, Kuroha Y, Miyazawa N, Tanaka S,Utsumi K, Ono K, Yano S, Hamano T, Naruse S, Yajima R, Kawashima N, Kaneko C, Tachibana H, Yano Y, Kato Y, Toue S, Jinzu H, Kitamura A,Yokoyama Y, Kaneko E, Yamakado M, Nagao K: Decreased circulating branched-chain amino acids are associated with development of Alzheimer’s disease in elderly individuals with mild cognitive impairment,Frontiers in Nutrition, 20221214, DOI: 10.3389/fnut.2022.1040476, #6.59
  14. Hamano T, Nagata M, Matsubara R, Ikebata Y, Ito T, Ibe A, Fujita Y,Kusaka Y, Tokunaga T, Enomoto S, Endo Y, Ueno A, Shirafuji N, Ikawa M,Hayashi K, Yamamura O, Nakamoto Y: Effectiveness of a self-reportingyes/no survey for dementia screening-trial in Fukui, Japan, Frontiers inAging Neuroscience, 14, 20230104, DOI:10.3389/fnagi.2022.1029614,#5.702
  15. Kitazaki Y, Ikawa M, Yamaguchi T, Enomoto S, Shirafuji N, Yamamura O, Tsujikawa T, Okazawa H, Kimura H, Nakamoto Y, Hamano T: Regional cortical hypoperfusion and atrophy correlate with striatal dopaminergic loss in Parkinson’s disease: a study using arterial spin labeling MR perfusion, Functional Neuroradiology, 65(3), 569-577, 202303, DOI:10.1007/s00234-022-03085-7, #2.995
  16. Nosaka T, Murata Y, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Imamura Y, Goi T, Nakamoto Y: Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumorassociated macrophages, Biomedicine & Pharmacotherapy, 202303, DOI:10.1016/j.biopha.2023.114592, #7.419
  17. 内藤 達志, 中本 安成: 特集 がんに対する新しい治療法と未来型医療 未来型医療の展望:AIを活用した医療の動向 3)内視鏡診断, 腫瘍内科, 29(5), 585-590, 20220528, DOI: 10.5692/clinicalneurol.cn-001472

2021

原著論文(審査有)

  1. Takahashi K, Ofuji K, Hiramatsu K, Nosaka T, Naito T, Matsuda H, Endo K, Higuchi M, Ohtani M, Nemoto T, Nakamoto Y: Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma, Cancer Med, 10(7), 2300-2309, 202104, DOI: 10.1002/cam4.3790, #4.452
  2. Yamamoto A, Matsuda H, Hiramatsu K, Tsuji A, Midori Y, Murata Y, Tanaka T, Tohda G, Nosaka T, Takahashi K, Naito T, Ofuji K, Ohtani M, Imamura Y, Nakamoto Y: A case of idiopathic portal hypertension accompanying multiple hepatic nodular regenerative hyperplasia in a patient with systemic sclerosis, Clin J Gastroenterol, 14(3), 820-826, 202106, DOI: 10.1007/s12328-021-01348-z(症例報告)
  3. Asaoka K, Watanabe Y, Itoh K, Hosono N, Hirota T, Ikawa M, Yamaguchi T, Hatta S, Imamura Y, Nishino I, Yamauchi T, Iwasaki H: A case of eosinophilic fasciitis without skin manifestations: a case report in a patient with lupus and literature review, Clin Rheumatol, 40(6), 2477-2483, 202106, DOI: 10.1007/s10067-020-05416-6(症例報告), #2.98
  4. Hiramatsu K, Naito T, Akazawa Y, Saito Y, Nosaka T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Matsuda M, Sakai A, Nakamoto Y: Bipolar-current needle-knife with a water jet function (Jet B-knife) shortens the procedure time of endoscopic submucosal dissection for colorectal tumors, Surg Endosc, 35(7), 3600-3606, 202107, DOI: 10.1007/s00464-020-07832-w, #4.584
  5. Ito Y, Goto T, Huh JY, Yamamura O, Hamano T, Kikuta KI, Hayashi H: Development of a Scoring System to Predict Prolonged Post-Stroke Dysphagia Remaining at Discharge from a Subacute Care Hospital to the Home, J Stroke Cerebrovasc Dis, 30(7), 105804, 202107, DOI: 10.1016/j.jstrokecerebrovasdis.2021.105804, #2.136
  6. Kumutpongpanich T, Ogasawara M, Ozaki A, Ishiura H, Tsuji S, Minami N, Hayashi S, Noguchi S, Iida A, Nishino I, OPDM_LRP12 Study Group, Mori-Yoshimura M, Oya Y, Ono K, Shimizu T, Kawata A, Shimohama S, Toyooka K, Endo K, Toru S, Sasaki O, Isahaya K, Takahashi MP, Iwasa K, Kira JI, Yamamoto T, Kawamoto M, Hamano T, Sugie K, Eura N, Shiota T, Koide M, Sekiya K, Kishi H, Hideyama T, Kawai S, Yanagimoto S, Sato H, Arahata H, Murayama S, Saito K, Hara H, Kanda T, Yaguchi H, Imai N, Kawagashira Y, Sanada M, Obara K, Kaido M, Furuta M, Kurashige T, Hara W, Kuzume D, Yamamoto M, Tsugawa J, Kishida H, Ishizuka N, Morimoto K, Tsuji Y, Tsuneyama A, Matsuno A, Sasaki R, Tamakoshi D, Abe E, Yamada S, Uzawa A: Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes, JAMA Neurol, 78(7), 853-863, 20210701, DOI: 10.1001/jamaneurol.2021.1509, #18.302
  7. Kitazaki Y, Ikawa M, Kishitani T, Kamisawa T, Nakane S, Nakamoto Y, Hamano T: Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM)-like Symptoms Associated with Anti-ganglionic Acetylcholine Receptor Antibodies, Intern Med, 60(14), 2307-2313, 20210715, DOI: 10.2169/internalmedicine.6419-20(症例報告), #1.271
  8. Yamashita T, Koshikawa N, Shimakami T, Terashima T, Nakagawa M, Nio K, Horii R, Iida N, Kawaguchi K, Arai K, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kitao A, Kobayashi S, Takahara S, Imai Y, Yoshimura K, Murayama T, Nakamoto Y, Yoshida E, Yoshimura T, Seiki M, Kaneko S: Serum laminin γ2 monomer as a novel diagnostic and predictive biomarker for hepatocellular carcinoma, Hepatology, 74(2), 760-775, 202108, DOI: 10.1002/hep.31758, #17.425
  9. Ohtani M, Ofuji K, Akazawa Y, Saito Y, Nosaka T, Ozaki Y, Takahashi K, Naito T, Matsuda H, Hiramatsu K, Nakamoto Y: Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer, Pancreas, 50(7), 1014-1019, 20210801, DOI: 10.1097/MPA.0000000000001873, #3.327
  10. Naito T, Nosaka T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Imamura Y, Ishizuka T, Nakamoto Y: A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis, Clin J Gastroenterol, 14(5), 1431-1436, 202110, DOI: 10.1007/s12328-021-01459-7(症例報告)
  11. Nosaka T, Ohtani M, Namikawa S, Takahashi K, Naito T, Ofuji K, Matsuda H, Hiramatsu K, Imamura Y, Nakamoto Y : Advanced primary adenosquamous carcinoma of the liver with a small cell carcinoma component: an autopsy case report, Clin J Gastroenterol, 14(5), 1496-1502, 202110, DOI: 10.1007/s12328-021-01474-8(症例報告)
  12. Matsuo H, Kubota M, Matsumura M, Takayama M, Mae Y, Kitazaki Y, Enomoto S, Ueno A, Ikawa M, Hamano T, Takahashi A, Tsubokawa M, Shimada S: Center of pressure velocities in patients with body lateropulsion: three case report series of Wallenberg’s syndrome, Physiother Theory Pract, 20211018, DOI: 10.1080/09593985.2021.1990448(症例報告), #2.279
  13. Kikuchi A, Yoneda M, Hasegawa T, Matsunaga A, Ikawa M, Nakamura T, Ezura M, Baba T, Sugeno N, Ishiyama S, Nakamoto Y, Takeda A, Aoki M: High prevalence of serum anti-NH 2-terminal of α-enolase antibodies in patients with multiple system atrophy and corticobasal syndrome, J Neurol, 268(11), 4291-4295, 202111, DOI: 10.1007/s00415-021-10553-2, #4.849
  14. Lin G, Zhu F, Kanaan NM, Asano R, Shirafuji N, Sasaki H, Yamaguchi T, Enomoto S, Endo Y, Ueno A, Ikawa M, Hayashi K, Yamamura O, Yen SH, Nakamoto Y, Hamano T: Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein, Int J Mol Sci, 22(21), 12063, 20211108, DOI: 10.3390/ijms222112063, #5.924
  15. Onishi H, Yamamura O, Tsubouchi H, Hirobe T, Kosugi I, Enomoto S, Yamamoto T, Daitoku S, Satou N, Chiba H, Kai Y, Hashimoto Y, Hamano T, Terasawa H: Long-Term Prevalence of Disaster-Related Deep Vein Thrombosis in Minamiaso Village After the 2016 Kumamoto Earthquakes: A Prospective Cross-Sectional Analysis, Disaster Med Public Health Prep, 20211119, DOI: 10.1017/dmp.2021.271, #1.385
  16. Tanaka T, Naito T, Midori Y, Nosaka T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Imamura Y, Yokoyama O, Naiki H, Nakamoto Y: Gastrointestinal AA amyloidosis secondary to chronic pyelonephritis presenting with refractory diarrhea and severe hypoalbuminemia, Clin J Gastroenterol, 14(6), 1642-1648, 202112, DOI: 10.1007/s12328-021-01508-1(症例報告)
  17. Ofuji K, Hiramatsu K, Nosaka T, Naito T, Takahashi K, Matsuda H, Ohtani M, Imamura Y, Ishizuka T, Nakamoto Y: Pembrolizumab‑induced autoimmune side effects of colon and pancreas in a patient with lung cancer, Clin J Gastroenterol, 14(6), 1692-1699, 202112, DOI: 10.1007/s12328-021-01499-z(症例報告) 
  18. Akazawa Y, Ohtani M, Namikawa S, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Hiramatsu K, Nakamoto Y: Severe necrotizing pancreatitis immediately after non-abdominal surgery under general anesthesia with propofol, Clin J Gastroenterol, 14(6), 1798-1803, 202112, DOI: 10.1007/s12328-021-01504-5(症例報告)
  19. Kitazaki Y, Shirafuji N, Takaku N, Yamaguchi T, Enomoto S, Ikawa M, Yamamura O, Nakamoto Y, Hamano T: Autoimmune basal ganglia encephalitis associated with anti-recoverin antibodies: A case report, eNeurologicalSci, 25, 100382, 202112, DOI: 10.1016/j.ensci.2021.100382(症例報告)
  20. Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Kurosaki M, Ido A, Miki D, Yoshiji H, Takikawa Y, Sakamori R, Hiasa Y, Nakao K, Ueno Y, Yatsuhashi H, Itoh Y, Tateishi R, Suda G, Takami T, Nakamoto Y, Asahina Y, Matsuura K, Yamashita T, Kanto T, Akuta N, Terai S, Shimizu M, Sobue S, Miyaki T, Moriuchi A, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T: Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis, J Gastroenterol, 57(2), 120-132, 202202, DOI: 10.1007/s00535-021-01845-5, #7.527
  21. Nosaka T, Naito T, Murata Y, Matsuda H, Ohtani M, Hiramatsu K, Nishizawa T, Okamoto H, Nakamoto Y: Regulatory Function of Interferon-Inducible 44 Like for Hepatitis B Virus cccDNA in Primary Human Hepatocytes, Hepatol Res, 52(2), 141-152, 202202, DOI: 10.1111/hepr.13722, #4.288
  22. Kitazaki Y, Ueno A, Maeda K, Asano R, Aoki G, Katsuki A, Shirafuji N, Yamaguchi T, Isozaki M, Saida T, Nakamoto Y, Hamano T: Primary diffuse large B-cell lymphoma of the central nervous system with rapidly progressing lesions after dimethyl fumarate treatment, showing relapsing and remitting symptoms: A case report, Clin Exp Neuroimmunol, 13(1), 60-65, 202202, DOI: 10.1111/cen3.12656(症例報告)
  23. Ikeuchi T, Yano Y, Sato W, Morikawa F , Toru S, Nishimura C, Miyazawa N , Kuroha Y, Koike R, Tanaka S, Utsumi K, Kasuga K, Tokutake T, Ono K, Yano S, Naruse S, Yajima R, Hamano T, Yokoyama Y, Kitamura A, Kaneko E, Yamakado M, Nagao K : Development of a Novel Nutrition-Related Multivariate Biomarker for Mild Cognitive Impairment Based on the Plasma Free Amino Acid Profile, Nutrients, 14(3), 637, 20220201, DOI: 10.3390/nu14030637, #5.719
  24. Takahashi K, Ofuji K, Nosaka T, Naito T, Matsuda H, Ohtani M, Hiramatsu K, Harada K, Naiki H, Nakamoto Y: Elderly onset congenital hepatic fibrosis with portal hypertension diagnosed after recurrent cholangitis: a case report, Clin J Gastroenterol, 20220324, DOI: 10.1007/s12328-022-01620-w(症例報告)
  25. 井川 正道, 米田 誠: ミトコンドリア脳筋症・乳酸アシドーシス・脳卒中様発作症候群(MELAS, 救急医学, 45(4), 461-467, 202104 
  26. 髙橋 和人, 中本 安成: 肝癌のCTC解析とバイオマーカーとしての意義(microcavity arrayなど), 肝胆膵, 83(4), 559-565, 20211028
  27. 平松 活志, 中本 安成: イメージング計測AIを用いた肝癌腫瘍内M2 Tumor-Associated Macrophageの細胞形態解析, 肝胆膵, 84(1), 51-56, 20220128

2020

原著論文(審査有)

  1. Onishi H, Yamamura O, Ueda S, Shibata M, Enomoto S, Maeda F, Tsubouchi H, Hirobe T, Shimizu S, Kishimoto T, Chiba H, Sasaki K, Hanzawa K, Hamano T, Nakamoto Y, Kaku B, Terasawa H: Deep-vein thrombosis detection rates and consideration of the living environment in a tsunami disaster area during the disaster reconstruction phase: A cross-sectional study, ACTA ANGIOLOGICA, 26(4), 129-139, 2020, DOI: 10.5603/AA.2020.0025
  2. Hamano T, Shirafuji N, Yen SH, Yoshida H, Kanaan NM, Hayashi K, Ikawa M, Yamamura O, Fujita Y, Kuriyama M, Nakamoto Y: Rho-kinase ROCK inhibitors reduce oligomeric tau protein, Neurobiol Aging, 89, 41-54, 202005, DOI: 10.1016/j.neurobiolaging.2019.12.009, #4.398
  3. Kitahara M, Mizukoshi E, Terashima T, Nakagawa H, Horii R, Iida N, Arai K, Yamashita T, Sakai Y, Yamashita T, Honda M, Nakamoto Y, Kaneko S: Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation, Transl Oncol, 13(7), 100777, 202007, DOI: 10.1016/ j.tranon.2020.100777, #3.558
  4. Akazawa Y, Saito Y, Yoshikawa T, Saito K, Nosaka K, Shimomura M, Mizuno S, Nakamoto Y, Nakatsura T: Effi cacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer , Cancer Sci, 111(8), 2736-2746, 202008, DOI: 10.1111/cas.14451, #4.966
  5. Indrawati LA, Iida A, Tanaka Y, Honma Y, Mizoguchi K, Yamaguchi T, Ikawa M, Hayashi S, Noguchi S, Nishino I: Two Japanese LGMDR25 patients with a biallelic recurrent nonsense variant of BVES, Neuromuscul Disord, 30(8), 674-679, 202008, DOI: 10.1016 / j.nmd.2020.06.004(症例報告), #3.115
  6. Matsuda H, Nosaka T, Akazawa Y, Saito Y, Ozaki Y, Takahashi K, Naito T, Ofuji K, Ohtani M, Hiramatsu K, Nakamoto Y: Daily Usage of Proton Pump Inhibitors May Reduce the Severity of Critical Upper Gastrointestinal Bleeding in Elderly Patients, Gastroenterol Res Pract, 2020, 7168621, 20200806, DOI: 10.1155/2020/7168621, #1.806
  7. Kitazaki Y, Ikawa M, Enomoto S, Shirafuji N, Hayashi K, Yamamura O, Yamada S, Arishima H, Noriki S, Nakamoto Y, Hamano T: An autopsy case of tuberculous meningitis undiagnosed by nested-PCR of CSF samples and brain biopsy, J Neurol Sci, 415, 116968, 20200815, DOI: 10.1016/j.jns.2020.116968(症例報告), #3.115
  8. Uesugi-Uchida S, Oyama N, Koizumi H, Hiramatsu K, Nakamoto Y, Hasegawa M: Tuberculosis-unrelated erythema induratum occurring after commencing tumor necrosis factor (TNF)-α antagonist therapy in a case with ulcerative colitis: A rare comorbidity interconnected by TNF-α blockade pathway, J Dermatol, 47(9), e326-e328, 202009, DOI: 10.1111/1346-8138.15486, #3.072
  9. Hama Y, Hamano T, Shirafuji N, Hayashi K, Ueno A, Enomoto S, Nagata M, Kimura H, Matsunaga A, Ikawa M, Yamamura O, Ito T, Kimura Y, Kuriyama M, Nakamoto Y: Infl uences of Folate Supplementation on Homocysteine and Cognition in Patients with Folate Defi ciency and Cognitive Impairment, Nutrients, 12(10), 3138, 20201014, DOI: 10.3390/nu12103138, #4.546
  10. Sakai K, Hamaguchi T, Sanjo N, Murai H, Iwasaki Y, Hamano T, Honma M, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Kitamoto T, Harada M, Mizusawa H, Yamada M: Diff usion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease, J Neurol Sci, 418, 117094, 20201115, DOI: 10.1016/j.jns.2020.117094, #3.115
  11. Okazawa H, Ikawa M, Tsujikawa T, Makino A, Mori T, Kiyono Y, Kosaka H: Noninvasive Measurement of [11C]PiB Distribution Volume Using Integrated PET/MRI, Diagnostics (Basel), 10(12), 993, 20201124, DOI: 10.3390/diagnostics10120993, #3.11
  12. Kitazaki Y, Ueno A, Maeda K, Asano R, Satomi H, Nishio T, Nakamoto Y, Hamano T: A case of longitudinally extensive transverse myelitis with an isolated pontine lesion following epidural and spinal anesthesia for cesarean section, eNeurologicalSci, 21, 100264, 202012, DOI: 10.1016/j.ensci.2020.100264(症例報告), #1.19
  13. Yamakawa M, Mukaino A, Kimura A, Nagasako Y, Kitazaki Y, Maeda Y, Higuchi O, Takamatsu K, Watari M, Yoshikura N, Ikawa M, Sugimoto I, Sakurai Y, Matsuo H, Ando Y, Shimohata T, Nakane S: Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis, J Neuroimmunol, 349, 577399, 20201215, DOI: 10.1016/j.jneuroim.2020.577399, #3.125
  14. Onishi H, Yamamura O, Tsubouchi H, Hirobe T, Enomoto S, Yamamoto T, Daitoku S, Mizukami Y, Kishimoto T, Kai Y, Hashimoto Y, Hamano T, Kaku B, Terasawa H: Hypertension treatment status and ultrasonic cardiography findings in temporary housing residents after the Kumamoto earthquake: a cross-sectional study, Arterial Hypertension, 25(2), 69-76, 2021, DOI: 10.5603/AH.a2021.0010
  15. Matsuda H, Ito K, Ishii K, Shimosegawa E, Okazawa H, Mishina M, Mizumura S, Ishii K, Okita K, Shigemoto Y, Kato T, Takenaka A, Kaida H, Hanaoka K, Matsunaga K, Hatazawa J, Ikawa M, Tsujikawa T, Morooka M, Ishibashi K, Kameyama M, Yamao T, Miwa K, Ogawa M, Sato N: Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer’s Disease: A Multicenter Study, Front Neurol, 11, 578753, 20210113, DOI: 10.3389/fneur.2020.578753, #2.889
  16. Ikawa M, Okazawa H, Yoneda M: Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders, Biochim Biophys Acta Gen Subj, 1865(3), 129832, 202103, DOI: 10.1016/j.bbagen.2020.129832, #3.422
  17. Koga Y, Povalko N, Inoue E, Ishii A, Fujii K, Fujii T, Murayama K, Mogami Y, Hata I, Ikawa M, Fukami K, Fukumoto Y, Nomura M, Ichikawa K, Yoshida K: A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection, JIMD, 44(2), 358-366, 202103, DOI: 10.1002/jimd.12317, #4.036
  18. 松田 秀岳, 吉田 祐未, 中本 安成: B型肝炎再活性化対策における高感度HBs抗原定量法とリスク遺伝子評価の実臨床応用に関する検討, 肝臓, 61(5), 242-243, 20200501, DOI: 10.2957/kanzo.61.242
  19. 北﨑 佑樹, 岩﨑 博道, 北井 隆平, 高橋 健太, 中道 一生, 濵野 忠則: 脳脊髄液中のJCV-DNA遺伝子検査が2回とも陰性であったが,開頭脳生検で診断確定したHIV関連進行性多巣性白質脳症の1例, BRAIN and NERVE-多発性硬化症の現在と未来, 72(5), 541-546, 20200501, DOI: 10.11477/ mf.1416201559
  20. 村田 陽介, 松田 秀岳, 中本 安成: 門脈血栓症に対するダナパロイドナトリウム療法, 肝胆膵, 81(3), 517-523, 20200928
  21. 北﨑 佑樹, 上野 亜佐子, 前田 健一郎, 浅野 礼, 宮山 士朗, 高畠 靖志: 脊髄症が急速進行し,longitudinally extensive spinal cord lesionと髄液中に多形核球優位の細胞上昇と糖低下をみとめた脊髄硬膜動静脈瘻の1例, 臨床神経学, 60(10), 699-705, 202010, DOI: 10.5692/clinicalneurol.cn-001472
  22. 浅野 礼, 北﨑 佑樹, 井川 正道, 呉林 秀崇, 小池 春樹, 濵野 忠則: 直腸肛門部悪性黒色腫の術後に両下肢の脱力をきたし免疫治療が奏効したpost-surgical inflammatory neuropathy の1例, 臨床神経学, 60(11), 762-767, 20201101
  23. 北﨑 佑樹, 浅野 礼, 林 浩嗣, 山村 修, 田邊 佐和香, 濵野 忠則: 胸背部痛を伴わないStanford A型大動脈解離に穿通枝領域の多発性脳梗塞を合併した1例, 臨床神経学, 60(12), 874-877, 20201201
  24. 濵野 忠則, 白藤 法道, 佐々木 宏仁, 山口 智久, 遠藤 芳徳, 武藤 多津郎, 中本 安成: タウ蛋白とオートファジー, 細胞, 53(1), 44-46, 20210120

    著書・総説・国際会議論文

    2024

    総説

    1. 赤澤 悠,野阪 拓人,中本 安成: 抗がん剤(免疫チェックポイント阻害薬を含む)による消化管粘膜傷害, 日本消化器病学会雑誌, 121(10), 813-824, 202410

    国際会議論文

    1. Akazawa Y, Nosaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Analysis of risk factors and longterm prognosis in patients with immune checkpoint inhibitor-induced pancreatic injury, Gastroenterology, 166(5), S-231-S-231, 20240518, #26.3
    2. Ohtani M, Akazawa Y, Nosaka T, Tanaka T, Takahashi K, Naito T, Matsuda H, Nakamoto Y: EVALUATION OF PANCREATIC STIFFNESS USING EUS WITH OPTIMAL ULTRASOUND SPEED IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM, Gastrointestinal Endoscopy, 99(6), AB844-AB844, 202406, #6.7
    3. Saito A, Nosaka T, Murata Y, Tanaka T, Akazawa Y, Naito T, Takahashi K, Ohtani M, Nakamoto Y: Association between Osteosarcopenia and Prognosis in Liver Cirrhosis Complicated with Portal Hypertension, APASL Oncology 2024 Chiba, 105-105, 20240829
    4. Nosaka T, Ohtani M, Yamashita J, Murata Y, Tanaka T, Akazawa Y, Takahashi K, Naito T, Nakamoto Y: Spatial Omics Analysis of the Proximity of PD-L1(+) Tumor-Associated Macrophage and CD8T cell Interaction Promoting Hepatocellular Carcinoma Progression, APASL Oncology 2024 Chiba, 94-94, 20240829
    5. Takahashi K, Nosaka T, Murata Y, Sugata R, Tanaka T, Akazawa Y, Naito T, Ohtani M, Nakamoto Y: Significance of Neutrophil-to-lymphocyte Ratio in Bleeding after Endoscopic Treatment of Cirrhotic Patients with Esophageal Varices, APASL Oncology 2024 Chiba, 127-127, 20240829
    6. Namikawa S, Nosaka T, Murata Y, Tanaka T, Akazawa Y, Takahashi K, Naito T, Ohtani M, Nakamoto Y: FUNCTIONAL ANALYSIS OF FUMARYLACETOACETATE HYDROLASE AS A HEPATOCYTE HOST FACTOR GENE REGULATING HEPATITIS B VIRUS REPLICATION AND HEPATOCARCINOGENESIS, HEPATOLOGY, 80(SupplementS1), S294-S295, 202410, DOI: 10.1097/HEP.0000000000001077, #13.0
    7. Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Ido A, Miki D, Kurosaki M, Yoshiji H, Sakamori R, KURODA H, Yatsuhasi H, Yamashita T, Hiasa Y, Kato N, Miyaaki H, Ueno Y, Itoh Y, Matsuura K, Takami T, Asahina Y, Suda G, Akuta N, Takeishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Kodama T, Tatsumi T,Yamada T, Takehara T,: FACTORS ASSOCIATED WITH THE AGGRAVATION OF GASTROESOPHAGEAL VARIX IN COMPENSATED AND DECOMPENSATED CIRRHOTIC PATIENTS DUE TO CHRONIC HEPATITIS C VIRUS INFECTION AFTER DIRECT-ACTING ANTIVIRAL THERAPY, HEPATOLOGY, 80(SupplementS1), S351-S353, 202410, DOI: 10.1097/HEP.0000000000001077, #13.0
    8. Tanaka T, Nosaka T, Murata Y, Sugata R, Akazawa Y, Naito T, Takahashi K, Ohtani M, Nakamoto Y: MULTISTEP HEPATOCARCINOGENESIS IN PRENEOPLASTIC NODULES ON EOB-MRI AFTER LONG-TERM SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C, HEPATOLOGY, 80(SupplementS1), S367-S367, 202410, DOI: 10.1097/HEP.0000000000001077, #13.0
    9. Murata Y, Nosaka T, Tanaka T, Akazawa Y, Takahashi K, Naito T, Ohtani M, Nakamoto Y: TGF-B SIGNALING MOLECULES IN CIRCULATING TUMOR CELLS AS PROGNOSTIC BIOMARKER IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB PLUS BEVACIZUMAB, HEPATOLOGY, 80(SupplementS1), S1372-S1373, 202410, DOI: 10.1097/ HEP.0000000000001077, #13.0
    10. Nosaka T, Ohtani M, Yamashita J, Murata Y, Tanaka T, Akazawa Y, Takahashi K, Naito T, Nakamoto Y: SPATIAL OMICS ANALYSIS OF THE PROXIMITY OF PD-L1(+) TUMOR-ASSOCIATED MACROPHAGE AND CD8T CELL INTERACTION PROMOTING HEPATOCELLULAR CARCINOMA PROGRESSION, HEPATOLOGY, 80(SupplementS1), S1427-S1427, 202410, DOI: 10.1097/HEP. 0000000000001077, #13.0
    11. Yamashita J, Nosaka T, Murata Y, Tanaka T, Akazawa Y, Naito T, Takahashi K, Ohtani M, Nakamoto Y: HIGH PROXIMITY OF TREGCD8T/CD4T CELL INTERACTIONS IN SPATIAL OMICS ANALYSIS REGULATING CANCER PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA, HEPATOLOGY, 80(SupplementS1), S1450-S1451, 202410, DOI: 10.1097/HEP.0000000000001077, #13.0
    12. Takahashi K, Nosaka T, Murata Y, Sugata R, Tanaka T, Akazawa Y, Naito T, Ohtani M, Nakamoto Y: SIGNIFICANCE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN BLEEDING AND PROGNOSIS AFTER ENDOSCOPIC TREATMENT OF CIRRHOTIC PATIENTS WITH ESOPHAGEAL VARICES, HEPATOLOGY, 80(SupplementS1), S1709-S1709, 202410, DOI: 10.1097/HEP.0000000000001077, #13.0

    2023

    著者(分担執筆)

    1. 中本 安成,山下 竜也,葛谷 貞二,平岡 淳,小笠原 定久:免疫チェックポイント阻害剤を巡る問題;適切なマネージメント: 肝臓vol.64 no.5, 日本肝臓学会, 217-227, 202305
    2. 野阪 拓人,中本 安成: Ⅱ.免疫微小環境 腫瘍関連マクロファージによる肝癌進展機構と治療標的: 肝胆膵 86巻5号, アークメディア,631-638, 202305
    3. 濵野 忠則: 炎症性筋疾患 皮膚筋炎: 筋疾患の骨格筋画像アトラス,医学書院, 23-30, 202305
    4. 濵野 忠則: 皮膚筋炎 抗合成酵素症候群: 筋疾患の骨格筋画像アトラス, 医学書院, 31-34, 202305
    5. 濵野 忠則: 皮膚筋炎 免疫介在性壊死性ミオパチー: 筋疾患の骨格筋画像アトラス, 医学書院, 35-39, 202305
    6. 濵野 忠則: 皮膚筋炎 封入体筋炎, 筋疾患の骨格筋画像アトラス,医学書院-42-44, 202305
    7. 濵野 忠則: 筋炎特異的自己抗体, 筋疾患の骨格筋画像アトラス, 医学書院-49-52, 202305
    8. 野阪 拓人, 中本 安成: B型肝炎 臨床をめざした基礎研究 獲得免疫によるcccDNAの制御, 日本臨牀 81巻増刊7, 日本臨牀社-287-292, 202307
    9. 松田 秀岳, 中本 安成: EMR(内視鏡的粘膜切除術), ESD(内視鏡的粘膜下層剥離術), 消化器ナーシング2023年秋季増刊, メディカ出版-27-30, 20230921
    10. 内藤 達志, 中本 安成: ポリープ切除術(ポリペクトミー), 消化器ナーシング2023年秋季増刊, メディカ出版-31-35, 20230921
    11. 中本 安成: 日本消化器病学会の取り組み(ビッグデータ・AI研究会),消化器内視鏡 第35巻 第12号, (株)東京医学社-1685-1687,20231225
    12. 松田 秀岳: ウイルス性肝炎の病態進展に関わるHLA-classⅡ領域遺伝子の多型解析, Precision Medicine, 北隆館-52-56, 20240111
    13. 大藤 和也: 薬物性肝障害drug-induced liver injury(DILI), 今日の治療指針 2024年版 私はこう治療している, 医学書院-548-550,202401
    14. 濵野 忠則: よくみる気になる神経症状・疾患へのアプローチ疼痛,感覚障害, 月刊 薬事, (株)じほう-19-24, 20240301

    総説

    1. 濵野 忠則, 高久 直子, 神澤 朋子, 野宮 廣貴: 神経筋疾患における筋肉CTとMRI, 脳神経内科, 99(2), 156-163, 2023082
    2. 濵野 忠則: オートファジーとアミロイドβ蛋白,タウ蛋白, 日本認知症学会誌, 38(1), 106-106, 20240115
    3. 濵野 忠則, 山口 智久, 佐々木 宏仁, 浅野 礼, 榎本 崇一:オートファジーとアミロイドβ蛋白,タウ蛋白, 日本認知症学会誌,38(1), 107-107, 20240115

    国際会議論文

    1. Ohtani M, Akazawa Y, Nosaka T, Takahashi K, Naito T, Matsuda H, Nakamoto Y:INCREASED RISK OF PANCREATIC MALIGNANCY IN PATIENTS WITH APPEARANCE OF WORRISOME FEATURES FOR FIVE YEARS OF DIAGNOSIS OF LOW-RISK BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS,Gastroenterology AGA Abstracts,164(6),S610-S610,202305
    2. Akazawa Y, Ohtani M, Nosaka T, Takahashi K, Naito T, Matsuda H, Matsuda H, Nakamoto Y:CLINICAL USEFULNESS OF BODY COMPOSITION ASSESSMENT USING 3D IMAGE ANALYSIS IN PREDICTING THE SEVERITY OF ACUTE,Gastroenterology AGA Abstracts,164(6),S384-S384,202305
    3. Murata Y, Nosaka T, Naito T, Takahashi K, Akazawa Y, Matsuda H, Ohtani M, Nakamoto Y:MOLECULAR SIGNATURE OF PERIPHERAL CIRCULATING TUMOR CELLS IN CANCER PROGRESSION OF HEPATOCELLULAR CARCINOMA PATIENTS TREATED BY ATEZOLIZUMAB PLUS,HEPATOLOGY,78(Supplement1),S95-S96,202310
    4. Nosaka T, Naito T, Akazawa Y, Takahashi K, Matsuda H, Ohtani M, Nakamoto Y:IDENTIFICATION OF NOVEL ANTIVIRAL HOST FACTORS BY FUNCTIONAL GENE EXPRESSION ANALYSIS USING IN VITRO HBV INFECTION ASSAY SYSTEMS,HEPATOLOGY,78(Supplement1),S602-S602,202310
    5. Namikawa S, Nosaka T, Akazawa Y, Naito T, Takahashi K, Matsuda H, Ohtani M, Nakamoto Y:HIGH CORRELATION OF HEPATIC SHEAR WAVE VELOCITY WITH ESOPHAGEAL VARICES COMPLICATION RATE IN PATIENTS WITH CHRONIC LIVER DISEASES,HEPATOLOGY,78(Supplement1),S1443-S1444,202310
    6. Yamamoto A, Nosaka T, Akazawa Y, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y:LYMPHOCYTE-RELATED NUTRITIONAL MARKERS AND MUSCLE VOLUME ASSESSMENT ARE USEFUL FOR PREDICTING PROGNOSIS IN LIVER CIRRHOSIS,HEPATOLOGY,78(Supplement1),S1446-S1447,202310
    7. Sugata R, Nosaka T, Akazawa Y, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y:EFFECTS OF PROTON BEAM THERAPY ON LOCAL CONTROL AND HEPATIC RESERVE IN UNRESECTABLE HEPATOCELLULAR CARCINOMA,HEPATOLOGY,78(Supplement1),S1835-S1835,202310

    2022

    著者(分担執筆)

    1. Hamano T,Endo Y: Autophagy and tau protein: Autophagy Dysfunction in Alzheimer’s Disease and Dementia,ELSEVIER, 135-158, 20220820
    2. Hamano T,Endo Y: Drug discovery in Alzheimer’s disease by regulating autophagy: Autophagy Dysfunction in Alzheimer’s Disease and Dementia, ELSEVIER, 253-290, 20220820
    3. 井川 正道: ミトコンドリア病: 今日の治療方針2023年版, 医学書院,987, 20230112

    国際会議論文

    1. Akazawa Y, Ohtani M, Nosaka T, Takahashi K, Naito T, Ofuji K,Matsuda H, Hiramatsu K, Nakamoto Y: Clinical Usefulness of SkeletalMuscle Quantity as Prognostic Factor in Elderly Patients with AdvancedPancreatic Cancer Receiving Nab-Paclitaxel Plus Gemcitabine Chemotherapy, Gastroenterology, 162(7), S-738, 20220501, DOI:10.1016/S0016-5085(22)61743-8, #33.883
    2. Ohtani M, Ofuji K, Akazawa Y, Nosaka T, Takahashi K, Naito T, Matsuda H, Hiramatsu K, Nakamoto Y: Risk Factors for Pancreatic Malignancies in Patients with Low-Risk Branch Duct Intraductal Papillary Mucinous Neoplasms after 5 Years of Long-Term Follow-Up, Gastroenterology,162(7), S-908, 20220501, DOI: 10.1016/S0016-5085(22)62152-8,#33.883
    3. Namikawa S: The Usefulness of Hepatic Shear Wave Velocity for Noninvasive Prediction of Esophageal Varices in Patients with ChronicLiver Diseases, APASL Oncology 2022 in Takamatsu, 226-226, 202209
    4. Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Yoshiji H,Kurosaki M, Ido A, Miki D, Kuroda H, Sakamoto R, Yatsuhahi H, Hiasa Y, Yamashita T, Kato N, Nakao K, Ueno Y, Itoh Y, Suda G, Takami T,Matsuura K, Tateishi R, Akuta N, Kakazu E, Nakamoto Y, Asahina Y,Terai S,Shimizu M,Kodama T,Tatsumi T,Yamada T,Takehara T: The Impact Of Changes In Liver Function After Direct-Acting Antiviral Therapy On The Prognosis In Hepatitis C Virus Patients With Decompensated,HEPATOLOGY, 76(Supplement1), S356-S358, 202210, DOI: 10.1002/hep.32697, #17.298
    5. Yamamoto A, Ofuji K, Naito T, Akazawa Y, Naito T, Takahashi K, Matsuda H, Ohtani M, Nakamoto Y: Increased Liver Volume Measuredusing a 3d Medical Imaging in Patients with Advanced Decompensated Cirrhosis Treated with Balloon-Occluded Retrograde Transvenous Obliteration (B-Rto), HEPATOLOGY, 76(Supplement1), S1145-S1146,202210, DOI: 10.1002/hep.32697, #17.298
    6. Namikawa S, Nosaka T, Akazawa Y, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Usefulness of Hepatic Shear Wave Velocity for Noninvasive Prediction of Esophageal Varices in Patients with Chronic Liver Diseases, HEPATOLOGY, 76(Supplement1), S1179-S1179, 202210,DOI: 10.1002/hep.32697, #17.298
    7. Midori Y, Hiramatsu K, Nosaka T, Akazawa Y, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Analysis of Mucosa-Associated Dysbiosis Related to Bile Acid Metabolism in Post-SVR Hepatitis C Patients Complicated with Esophageal Varices, HEPATOLOGY,76(Supplement1), S1286-S1297, 202210, DOI: 10.1002/hep.32697,#17.298
    8. Tanaka T, Nosaka T, Murata Y, Akazawa Y, Takahashi K, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Influence of Lifestyle-Related Factors on Hypervascularization in Preneoplastic Nodules of Hepatocellular Carcinoma after HCV Eradication, HEPATOLOGY, 76(Supplement1),S1322-S1322, 202210, DOI: 10.1002/hep.32697, #17.298
    9. Nosaka T, Murata Y, Akazawa Y, Naito T, Takahashi K, Matsuda H, Ohtani M, Nakamoto Y: Hepatocellular Carcinoma-Derived GM-CSF Induces Leukotriene Production in Tumor-Associated Macrophages Contributing to Tumor Progression, HEPATOLOGY, 76(Supplement1),S1343-S1344, 202210, DOI: 10.1002/hep.32697, #17.298
    10. Murata Y, Nosaka T, Akazawa Y, Naito T, Takahashi K, Matsuda H, Ohtani M, Nakamoto Y: Stem Cell Signature of Peripheral Circulating Tumor Cells correlated with therapeutic effects of Atezolizumab plus Bevacizumab in unresectable HCC patients, HEPATOLOGY,76(Supplement1), S1365-S1366, 202210, DOI: 10.1002/hep.32697,#17.298
    11. Arinaga-Hino T, Ohira H, Takahashi A, Takai A, Sogo T, Inui A, Fujisawa T, Abe M, Kang J, Koike K, Kondo Y, Nakamoto M, Nakamoto Y, Joshita S, Zeniya M, Kawaguchi T, Tanaka A: Characteristics Of Overlap Of Autoimmune Hepatitis And Primary Biliary Cholangitis In Japan: A Nationwide Survey, HEPATOLOGY, 76(Supplement1), S1469-S1470,202210, DOI: 10.1002/hep.32697, #17.2982021

    2021

    著者(分担執筆)

    1. 濵野 忠則: 抗認知症薬による治療: 認知症診療実践ハンドブック, 中外医学社, 150-166, 20210415 
    2. 平松 活志, 中本 安成: C型肝疾患の免疫病態: 消化器内科Vol.3 No.7, 医学出版, 63-71, 20210701 
    3. 平松 活志, 中本 安成: 肝疾患と獲得免疫の関わり: 専門医のための消化器病学, 医学書院, 424-425, 20211101
    4. 濵野 忠則: 物質の脳沈着による神経変性(鉄,ヘモジデリン,カルシウム): 最新主要文献とガイドラインでみる 脳神経内科学レビュー 2022-’23, 総合医学社, 154-159, 20220325
    5. 井川 正道: ミトコンドリア病: 最新主要文献とガイドラインでみる 脳神経内科学レビュー 2022-’23, 総合医学社, 361-366, 20220325

    総説

    1. Hamano T, Enomoto S, Shirafuji N, Ikawa M, Yamamura O, Yen SH, Nakamoto Y: Autophagy and Tau Protein, Int J Mol Sci, 22(14), 7475, 20210712, DOI: 10.3390/ijms22147475, #5.923
    2. 濵野 忠則, 山口 智久, 佐々木 宏仁, 白藤 法道: タウオパチーとオートファジー, 脳神経内科, 95(4), 448-457, 202110
    3. 濵野 忠則, 浅野 礼, 佐々木 宏仁, 山口 智久, 北﨑 佑樹, 遠藤 芳徳, 濵 由香, 榎本 崇一, 白藤 法道, 中本 安成: タウ蛋白とオートファジー, 細胞, 53(12), 781-783, 202110
    4. 濵野 忠則, 白藤 法道, 山口 智久, 佐々木 宏仁, 中本 安成: Rho-ROCK阻害薬によるタウ蛋白オリゴマー形成抑制, 細胞, 54(1), 50-54, 20220120
    5. 内藤 達志, 中本 安成: 食物蛋白誘発胃腸症, 消化器・肝臓内科, 11(2), 150-156, 202202

    国際会議論文

    1. Ohtani M, Ofuji K, Akazawa Y, Nosaka T, Takahashi K, Naito T, Matsuda H, Hiramatsu K, Nakamoto Y: Rapid Growth Rates of Cysts Associates with Pancreatic Malignancy in Low Risk Branch-duct Intraductal Papillary Mucinous Neoplasms, Gastroenterology, 160(6), S-477, 202105, DOI: 10.1016/S0016-5085(21)01846-1, #22.682
    2. Takahashi K, Matsuda H, Nosaka T, Naito T, Ofuji K, Ohtani M, Hiramatsu K, Nakamoto Y : Influence of Antiplatelet Drugs on Gastric Ulcer Healing after Endoscopic Submucosal Dissection, Gastroenterology, 160(6), S-650-S-651, 202105, DOI: 10.1016/S0016-5085(21)02267-8, #22.682
    3. Akazawa Y, Ohtani M, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Hiramatsu K, Nakamoto Y: Clinical Usefulness of Pancreatic Volume Quantitative Analysis as a Predictor of the Onset and Severity in Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis, GIE, 93(6), AB158, 20210601, DOI: 10.1016/j.gie.2021.03.319, #9.427
    4. Midori Y, Hiramatsu K, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Nakamoto Y: Analysis of Mucosa-Associated Dysbiosis Related to Portal Hypertension and Liver Fibrosis in Hepatitis C Patients, HEPATOLOGY, 74(Supplement1), 352A-353A, 202110, #17.425
    5. Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Kurosaki M, Ido A, Miki D, Yoshiji H, Takikawa Y, Sakamori R, Hiasa Y, Nakao K, Kato N, Ueno Y, Yatsuhashi H, Itoh Y, Tateishi R, Suda G, Takami T, Yamashita T, Nakamoto Y, Asahina Y, Matsuura K, Kanto T, Akuta N, Terai S, Shimizu M, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T: The Real-World Impact of Direct-Acting Antiviral Treatment on Liver-Related Events in Patients with Hepatitis C Virus-Associated Cirrhosis, HEPATOLOGY, 74(Supplement1), 578A-579A, 202110, #17.425
    6. Tanaka T, Murata Y, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Baseline FIB4 Index, Albumin, and ALBI Scores Predict Hypervascularization in Preneoplastic Nodules of Hepatocellular Carcinoma after HCV Eradication, HEPATOLOGY, 74(Supplement1), 680A, 202110, #17.425
    7. Murata Y, Nosaka T, Naito T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Comparison of Circulating Tumor Cells in Hepatocellular Carcinoma Patients Treated by Atezolizumab-Bevacizumab and Transcatheter Arterial Chemoembolization, HEPATOLOGY, 74(Supplement1), 682A, 202110, #17.425
    8. Nosaka T, Murata Y, Naito T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Leukotrienes Derived from Tumor-Infiltrating Macrophages Promote Hepatocellular Carcinoma Progression, HEPATOLOGY, 74(Supplement1), 699A-700A, 202110, #17.425
    9. Hiramatsu K, Nosaka T, Yamamoto A, Saito Y, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Nakamoto Y: Morphological Analysis of M2 Tumor-Associated Macrophage Subsets in Patients with Hepatocellular Carcinoma using Machine Learning Algorithm, HEPATOLOGY, 74(Supplement1), 703A, 202110, #17.425                                                           
    10. Ofuji K, Nosaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Pre-Existing Autoimmune Disease Is a Potential Risk of Immune-Mediated Hepatotoxicity Caused by Immune Check Point Inhibitor Therapy in Japanese Patients with Solid Malignancies, HEPATOLOGY, 74(Supplement1), 732A, 202110, #17.425
    11. Nosaka T, Murata Y, Naito T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Leukotrienes Derived from Tumor-Infiltrating Macrophages Enhance the Progression of Hepatocellular Carcinoma, Program and Abstracts, 87, 20211002
    12. Hiramatsu K, Nosaka T, Yamamoto A, Saito Y, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Nakamoto Y: Morphological Analysis of CD163-positive Tumor Associated Macrophage in Patients with Hepatocellular Carcinoma, Program and Abstracts, 94, 20211002
    13. Tanaka T, Murata Y, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Baseline high FIB4 index, low Albumin, and high ALBI Scores Predict Hypervascularization in Preneoplastic Nodules of Hepatocellular Carcinoma after HCV Eradication, Program and Abstracts, 100, 20211002
    14. Nosaka T: Leukotrienes Derived from Tumor-Infiltrating M2 Macrophages Promote the Progression of Hepatocellular Carcinoma, APASL Oncology 2021 in Tokyo, 62, 202112
    15. Asano R, Hamano T, Yen SH, Sasaki H, Yamaguchi T, Endo Y, Enomoto S, Shirafuji N, Ikawa M, Yamamura O, Nakamoto Y: Lithium chloride inhibits phosphorylation of tau protein, Alzheimer’s & Dementia, 17(Suppl 9), e054807, 20211231, DOI: 0.1002/alz.054807, #21.566

    2020

    著者(分担執筆)

    1. Ikawa M, Matsunaga A, Yoneda M: Young woman feeling sick and confused: Case Studies in Dementia: Volume 2, Cambridge University Press, 124-126, 20210318
    2. 井川 正道, 米田 誠: MERRF: 遺伝子医学MOOK35号 ミトコンドリアと病気, メディカルドゥ, 138-142, 20200510

    総説

    1. Ikawa M, Okazawa H, Nakamoto Y, Yoneda M: PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction, Antioxidants (Basel), 9(9), E861, 20200914, DOI: 10.3390/antiox9090861, #5.014
    2. 松田 秀岳, 中本 安成: 化膿性肝膿瘍, 別冊日本臨牀 領域別症候群シリーズNo.13 肝・胆道系症候群(第3版)I 肝臓編(上)-その他の肝・胆道系疾患を含めて-,( 13), 54-58, 20210131

    国際会議論文

    1. Ohtani M, Ofuji K, Nosaka T, Takahashi K, Naito T, Matsuda H, Hiramatsu K, Nakamoto Y: Clinical Usefulness of FDG-PET/CT for Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer, Gastroenterology, 158(6), S-1135, 202005, DOI: 10.1016/S0016-5085(20)33506-X, #17.373
    2. Hiramatsu K, Naito T, Nosaka T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Nakamoto Y: Efficacy and Safety of Hookknife Electrosurgical Knife in Endoscopic Submucosal Dissection for the Treatment of Superficial Non-Ampullary Duodenal Epithelial Tumor, GIE, 91(6), AB260-AB261, 20200601, DOI: 10.1016/ j.gie.2020.03.1849, #6.890
    3. Nosaka T, Murata Y, Naito T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nishizawa T, Okamoto H, Nakamoto Y: Identification of IFN-gamma Mediated Regulatory Molecules for Hepatitis B Virus Clones in Primary Human Hepatocytes, Hepatology, 72(Supplement1), 516A, 202011, #14.679
    4. Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, Yoshiji H, Miki D, Hiasa Y, Takikawa Y, Kurosaki M, Yatsuhashi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Matsuura K, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T: Improvement in Serum Albumin Levels after Directacting Antivirals Treatment for Patients with Hepatitis C Virusrelated Cirrhosis Depends on the Baseline Serum Albumin Levels, Hepatology, 72(Supplement1), 535A-536A, 202011, #14.679
    5. Hiramatsu K, Nosaka T, Saito Y, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Nakamoto Y: Analysis of Immune Microenvironment of Hepatocellular Carcinoma after Hepatitis C Virus Eradication, Hepatology, 72(Supplement1), 658A-659A, 202011, #14.679
    6. Tanaka T, Murata Y, Nosaka T, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nakamoto Y: Signal Changes in Preneoplastic Nodules on DWI of Gd-EOB-DTPA MRI in Patients at Risk for Hypervascular Hepatocellular Carcinoma, Hepatology, 72(Supplement1), 686A, 202011, #14.6
    7. Takahashi K, Ofuji K, Hiramatsu K, Nosaka T, Naito T, Matsuda H, Ohtani M, Nakamoto Y: Circulating Tumor Cells Detected with Microcavity Array Predict Clinical Outcome in Patients with Hepatocellular Carcinoma, Hepatology, 72(Supplement1), 690A, 202011, #14.679
    8. Murata Y, Matsuda H, Nosaka T, Takahashi K, Naito T, Ofuji K, Ohtani M, Hiramatsu K, Nakamoto Y: Efficacy of Early Initiation of Anticoagulant Therapy for Portal Vein Thrombosis in Chronic Liver Disease Patients with Hyponatremia, Hepatology, 72(Supplement1), 1067A-1068A, 202011, #14.679
    9. Yamaguchi T, Hamano T, Sada K, Kanaan NM, Sasaki H, Yen SH, Asano R, Enomoto S, Shirafuji N, Ueno A, Ikawa M, Yamamura O, Nakamoto Y: Syk inhibitor reduces oligomeric tau associated with GSK3β inactivation and autophagy activation, Alzheimer’s & Dementia, 16(Suppl 3), e042633, 20201207, DOI: 10.1002/ alz.042633, #17.127
    10. Zhu F, Lin G, Hamano T, Kanaan NM, Yen SH, Asano R, Shirafuji N, Sasaki H, Enomoto S, Yamaguchi T, Ueno A, Ikawa M, Yamamura O, Nakamoto Y: Clioquinol reduces tau phosphorylation and oligomerization, Alzheimer’s & Dementia, 16(Suppl 3), e044356, 20201207, DOI: 10.1002/alz.044356, #17.127

      その他刊行物

      2022

      その他研究等実績(報告書を含む)

      1. 中本 安成: 安全に施行するためのESDテクニック, 週間 医学界新聞,( 3486), 6, 20220919

      2021

      その他研究等実績(報告書を含む)

      1. 中本 安成: 19回日本免疫治療学会学術集会を担当するにあたって, 日本免疫治療学会誌(JRAI Report Vol.9), 9, 26, 202112
      2. 中本 安成: AIのすゝめ, 肝胆膵, 84(1), 5-7, 20220128

      2020

      その他研究等実績(報告書を含む)

      1. Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A: Statin Intolerance Clinical Guide 2018, J Atheroscler Thromb, 27(4), 375-396, 20200401, DOI: 10.5551/jat.50948, #3.478
      2. Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, Yoshiji H, Miki D, Hiasa Y, Takikawa Y, Sakamori R, Kurosaki M, Yatsuhashi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T: Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese realworld multicenter study, J Gastroenterol, 56(1), 67-77, 202101, DOI: 10.1007/s00535-020-01733-4, #6.132
      3. 北村 和哉, 中村 慶史, 加賀谷 尚史, 松田 耕一郎, 平松 活志: 多発小腸狭窄を有するクローン病の治療方針, IBDクリニカルカンファレンス, 2(3), 6-13, 202008
      4. 中本 安成: 新理事の抱負, 肝臓, 62(2), 45, 20210125

        消化器内科学研究室

        TEL
        0776-61-3111
        FAX
        0776-61-8110